Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.61

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (6087)	4/4/2002 2:17:28 PM
From: Jibacoa	Read Replies (1) of 52153

Tuck: Do you know if CIPH's SELDI P.Chip will be used to detect osteopontin or if they have another "marker" for detection of ovarian Ca ? I read with interest the article on JAMA.2002;287:1671-1679 Dr.S.C.Mok, the senior author, is from Boston's Brigham & Women's Hospital. The ELISA kits that were used reportedly were supplied by Immuno-Biological Labs. which I understand has applied for a patent for osteopontin detection kits. They stated that there are a variety of arbitrary choices for reporting specificity and sensitivity estimates and with their choice of reporting.<g> their specificity result was 80%. That was less than the 96% on the article you mentioned in which the study apparently was done by Northwestern ? RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next